Pfizer to buy Wyeth for $68 billion, cuts dividend (Reuters)

Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, speak during a news conference announcing the merger of the two companies in New York, January 26, 2009. (Brendan McDermid/Reuters)Reuters – Pfizer Inc, the No. 1 drugmaker, said on Monday that it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.

Leave a Reply